Emergent BioSolutions Inc (NYSE:EBS)

28.52
Delayed Data
As of Mar 27
 +0.67 / +2.41%
Today’s Change
19.31
Today|||52-Week Range
30.96
+4.74%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues53.9M110.3M138.0M119.5M
 
 
 
 
 
Cost of Goods Sold12.2M26.0M23.4M24.3M
 
 
 
 
 
Depreciation And Amortization6.8M8.5M9.0M8.2M
 
 
 
 
 
 
Operating ExpensesGross Income34.9M75.8M105.5M87.0M
 
 
 
 
 
General Expenses56.6M68.0M74.5M70.9M
 
 
 
 
 
Research And Development30.3M37.4M44.2M39.0M
 
 
 
 
 
Total Operating Expenses75.6M102.5M106.9M103.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.8M7.9M31.0M16.1M
 
 
 
 
 
Extraordinary Charge-3.7M------
 
 
Interest Expense On Debt4.1M2.2M2.3M1.2M
 
 
 
 
 
Other Expenses512.0K1.3M420.0K29.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-28.4M7.5M29.7M44.3M
 
 
 
 
 
Income Taxes-8.2M-2.5M-7.9M-14.2M
 
 
 
 
 
Net Income-20.2M5.0M21.8M30.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS36.9M37.4M37.5M37.6M
 
 
 
 
 
Shares To Calculate EPS Diluted36.9M38.3M46.6M46.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.55$0.13$0.49$0.66
 
 
 
 
 
EPS Diluted-$0.55$0.13$0.47$0.66
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account